Mark Guthrie is a Global Access Strategy Leader for Oncology at Roche, focusing on Lung, Skin, and Rare Mutations. With over 15 years of experience in global pricing and reimbursement, Mark previously led efforts in Immunology, Infectious Disease, and Ophthalmology at Roche, while also serving in senior roles at GlaxoSmithKline and Genentech. Mark has developed strategic pricing and access solutions, conducted policy analyses, and engaged with federal policymakers to advocate for access to medicines. Holding an MBA in Healthcare Management and a BA in Economics, Mark brings a comprehensive understanding of the pharmaceutical landscape and pricing strategies across various global markets.
This person is not in the org chart
This person is not in any teams
This person is not in any offices